These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 25980427)
1. Classical swine fever virus marker vaccine strain CP7_E2alf: Shedding and dissemination studies in boars. Dräger C; Petrov A; Beer M; Teifke JP; Blome S Vaccine; 2015 Jun; 33(27):3100-3. PubMed ID: 25980427 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes. Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658 [TBL] [Abstract][Full Text] [Related]
3. First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions. Feliziani F; Blome S; Petrini S; Giammarioli M; Iscaro C; Severi G; Convito L; Pietschmann J; Beer M; De Mia GM Vaccine; 2014 Apr; 32(18):2050-5. PubMed ID: 24565752 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1. Dräger C; Schröder C; König P; Tegtmeyer B; Beer M; Blome S Vaccine; 2016 Sep; 34(39):4666-4671. PubMed ID: 27523739 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies. Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909 [TBL] [Abstract][Full Text] [Related]
6. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species. König P; Blome S; Gabriel C; Reimann I; Beer M Vaccine; 2011 Dec; 30(1):5-8. PubMed ID: 22064266 [TBL] [Abstract][Full Text] [Related]
7. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity. Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108 [TBL] [Abstract][Full Text] [Related]
8. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine. Koenig P; Hoffmann B; Depner KR; Reimann I; Teifke JP; Beer M Vet Microbiol; 2007 Mar; 120(3-4):343-51. PubMed ID: 17147979 [TBL] [Abstract][Full Text] [Related]
9. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Reimann I; Depner K; Trapp S; Beer M Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124 [TBL] [Abstract][Full Text] [Related]
10. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). Koenig P; Lange E; Reimann I; Beer M Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713 [TBL] [Abstract][Full Text] [Related]
11. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf". Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022 [TBL] [Abstract][Full Text] [Related]
13. Classical swine fever virus marker vaccine strain CP7_E2alf: genetic stability in vitro and in vivo. Goller KV; Dräger C; Höper D; Beer M; Blome S Arch Virol; 2015 Dec; 160(12):3121-5. PubMed ID: 26392285 [TBL] [Abstract][Full Text] [Related]
14. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies. Eblé PL; Quak S; Geurts Y; Moonen-Leusen HW; Loeffen WL Vet Microbiol; 2014 Nov; 174(1-2):27-38. PubMed ID: 25265929 [TBL] [Abstract][Full Text] [Related]
16. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies. Aebischer A; Müller M; Hofmann MA Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of C-strain "Riems" or CP7_E2alf vaccinated animals from animals infected by classical swine fever virus field strains using real-time RT-PCR. Leifer I; Depner K; Blome S; Le Potier MF; Le Dimna M; Beer M; Hoffmann B J Virol Methods; 2009 Jun; 158(1-2):114-22. PubMed ID: 19428579 [TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination. Blome S; Aebischer A; Lange E; Hofmann M; Leifer I; Loeffen W; Koenen F; Beer M Vet Microbiol; 2012 Jul; 158(1-2):42-59. PubMed ID: 22397931 [TBL] [Abstract][Full Text] [Related]
19. Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus. Renson P; Le Dimna M; Gabriel C; Levai R; Blome S; Kulcsar G; Koenen F; Le Potier MF Res Vet Sci; 2014 Apr; 96(2):389-95. PubMed ID: 24530018 [TBL] [Abstract][Full Text] [Related]
20. Two real-time RT-PCR assays of classical swine fever virus, developed for the genetic differentiation of naturally infected from vaccinated wild boars. Liu L; Hoffmann B; Baule C; Beer M; Belák S; Widén F J Virol Methods; 2009 Jul; 159(1):131-3. PubMed ID: 19442858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]